Home > Insider Trading > Filing (0001181431-12-040385)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
827809	Qlt Inc	QLTI	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1182504	Boyd C Clarke	1423 Colton Road Gladwyne PA 19035		No	No	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-07-09	55,450	$7.62	0	No	4	S	Direct
Common Stock	Disposition	2012-07-09	20,000	$7.62	0	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	See Footnote

Footnotes

This sale was executed in U.S. Dollars. This transaction was executed in multiple trades in prices ranging from USD $7.522 to $7.71, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer information regarding the number of shares and prices at which the transaction was effected.
This sale was executed in U.S. Dollars. This transaction was executed in multiple trades in prices ranging from USD $7.565 to $7.71, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer information regarding the number of shares and prices at which the transaction was effected.
These shares are held by the Henry Crofton Clarke Memorial Foundation (the "Foundation"). The Reporting Person serves as President of the Foundation, and therefore may be deemed to beneficially own the shares held by the Foundation. The Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of his proportionate pecuniary interest therein.